适度至重度喘的成年患者的治疗选择:TAILOR研究
Daniel Jeannetot1, Maria de Ridder1, Mees Mosseveld1
1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.
ERJ open research
|July 1, 2025
概括
在患有非控制性喘的患者中,在老年人和患有慢性肺炎的患者中,添加长效肌抗体 (LAMA) 于吸入性皮质类固醇/长效β2激动剂 (ICS/LABA) 治疗是更常见的. 这种现实世界的治疗选择不同于指南.
科学领域:
- 肺部医学 肺部医学
- 药物治疗 药物治疗
- 现实世界的证据 现实世界的证据
背景情况:
- 目前的喘指南建议增加吸入性皮质类固醇/长效β2激动剂 (ICS/LABA) 剂量,或在未控制的喘中添加长效肌抗剂 (LAMA).
- 将LAMA添加到高剂量的ICS/LABA中,这不是第四阶段喘的标准,但是在临床实践中发生的.
- 选择特定的喘治疗升级方案的决定因素尚不清楚.
研究的目的:
- 确定影响中度至重度喘患者治疗阶段化决策的患者特征.
- 为了比较与升级到中剂量ICS/LABA+LAMA与高剂量ICS/LABA相关的因素.
- 调查超出指南建议的现实世界治疗模式.
主要方法:
- 使用多个初级保健和处方数据库的回顾性队列研究.
- 包括成人喘患者,接受中剂量ICS/LABA治疗至少3个月,随后接受治疗升级.
- 分析了患者的人口统计,并发性疾病 (例如,慢性肺炎) 和治疗选择 (中剂量ICS/LABA+LAMA与高剂量ICS/LABA).
主要成果:
- 从近50万名患有喘的成年人中,分析了超过25,000名符合条件的患者.
- 升级到中剂量ICS/LABA+LAMA与更高的年龄,目前的吸烟,之前的喘恶化和COPD诊断有关.
- 亚托皮病史与选择ICS/LABA+LAMA治疗的可能性较低有关.
结论:
- 在现实实践中,老年患者,当前吸烟者,喘恶化患者和COPD患者更有可能接受附加LAMA治疗.
- 这些发现突出了影响喘治疗强化超出标准指导方针的患者特定因素.
- 了解这些决定因素可以为不受控制的喘提供个性化治疗策略.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:30Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
01:19Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495
01:20Asthma: Pathogenesis and Management
613
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
613
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K